Form D · Other
BIOHM Health Inc.
Cleveland, OH · CIK 0001960951
Offering snapshot reported Feb 27, 2025 · SEC filing
- Reported sold
- $1.5M Offering amount: $1.5M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 11, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 27, 2025 | Initial | $1,500,000 | No comparison | 1 | SEC filing |
| Dec 31, 2024 | Initial | $3,019,118 | No comparison | 8 | SEC filing |
| Dec 1, 2023 | Initial | $1,000,000 | No comparison | 1 | SEC filing |
| Jan 13, 2023 | Initial | $5,538,224 | No comparison | 26 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-539331
Source: Form D, filed Feb 27, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Kyle Fisher | Director |
| Ellis Fried | Director |
| Afif Ghannoum | Director |
| Mahmoud Ghannoum | Director |
| Michael Haritakis | Executive |
| Steven Himmel | Director |
| Brian Mixer | Director |
| Bob Pavey | Director |
| Scott Ravech | Director |
| Sam Schatz | Executive |
Issuer details
Industry: Other (See others in industry)
Address:
425 Literary Road Suite 100
Cleveland, OH, 44113
Cleveland, OH, 44113